Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Medtronic
McKesson
Johnson and Johnson
Dow

Last Updated: August 14, 2022

Investigational Drug Information for Larazotide


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the development status for investigational drug Larazotide?

Larazotide is an investigational drug.

There have been 9 clinical trials for Larazotide. The most recent clinical trial was a Phase 2 trial, which was initiated on May 29th 2019.

The most common disease conditions in clinical trials are Celiac Disease, Syndrome, and COVID-19. The leading clinical trial sponsors are 9 Meters Biopharma, Inc., Alba Therapeutics, and Teva Pharmaceuticals USA.

There are two US patents protecting this investigational drug and thirty-six international patents.

Recent Clinical Trials for Larazotide
TitleSponsorPhase
AT1001 for the Treatment of COVID-19 Related MIS-CMassachusetts General HospitalPhase 2
Study to Evaluate the Efficacy and Safety of Larazotide Acetate for the Relief of CeD Symptoms9 Meters Biopharma, Inc.Phase 3
Study to Evaluate the Efficacy and Safety of Larazotide Acetate for the Relief of CeD SymptomsInnovate BiopharmaceuticalsPhase 3

See all Larazotide clinical trials

Clinical Trial Summary for Larazotide

Top disease conditions for Larazotide
Top clinical trial sponsors for Larazotide

See all Larazotide clinical trials

US Patents for Larazotide

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Larazotide See Plans and Pricing Gluten-related disorders H.J. Heinz Company Brands LLC (Pittsburgh, PA) See Plans and Pricing
Larazotide See Plans and Pricing Larazotide acetate compositions Alba Therapeutics Corporation (Baltimore, MD) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Larazotide

Drugname Country Document Number Estimated Expiration Related US Patent
Larazotide Australia AU2013277316 2032-06-18 See Plans and Pricing
Larazotide Australia AU2018203543 2032-06-18 See Plans and Pricing
Larazotide Brazil BR112014031666 2032-06-18 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Medtronic
McKesson
Johnson and Johnson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.